357 related articles for article (PubMed ID: 32483117)
1. Suppression of unwanted CRISPR-Cas9 editing by co-administration of catalytically inactivating truncated guide RNAs.
Rose JC; Popp NA; Richardson CD; Stephany JJ; Mathieu J; Wei CT; Corn JE; Maly DJ; Fowler DM
Nat Commun; 2020 Jun; 11(1):2697. PubMed ID: 32483117
[TBL] [Abstract][Full Text] [Related]
2. CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs.
Coelho MA; De Braekeleer E; Firth M; Bista M; Lukasiak S; Cuomo ME; Taylor BJM
Nat Commun; 2020 Aug; 11(1):4132. PubMed ID: 32807781
[TBL] [Abstract][Full Text] [Related]
3. Genome Editing with CRISPR-Cas9: Can It Get Any Better?
Haeussler M; Concordet JP
J Genet Genomics; 2016 May; 43(5):239-50. PubMed ID: 27210042
[TBL] [Abstract][Full Text] [Related]
4. Optimizing sgRNA length to improve target specificity and efficiency for the GGTA1 gene using the CRISPR/Cas9 gene editing system.
Matson AW; Hosny N; Swanson ZA; Hering BJ; Burlak C
PLoS One; 2019; 14(12):e0226107. PubMed ID: 31821359
[TBL] [Abstract][Full Text] [Related]
5. Optimization of genome editing through CRISPR-Cas9 engineering.
Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
[TBL] [Abstract][Full Text] [Related]
6. [CRISPR/CAS9, the King of Genome Editing Tools].
Bannikov AV; Lavrov AV
Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
[TBL] [Abstract][Full Text] [Related]
7. Targeted genome editing in human cells using CRISPR/Cas nucleases and truncated guide RNAs.
Fu Y; Reyon D; Joung JK
Methods Enzymol; 2014; 546():21-45. PubMed ID: 25398334
[TBL] [Abstract][Full Text] [Related]
8. Boosting activity of high-fidelity CRISPR/Cas9 variants using a tRNA
He X; Wang Y; Yang F; Wang B; Xie H; Gu L; Zhao T; Liu X; Zhang D; Ren Q; Liu X; Liu Y; Gao C; Gu F
J Biol Chem; 2019 Jun; 294(23):9308-9315. PubMed ID: 31010827
[TBL] [Abstract][Full Text] [Related]
9. Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field.
He ZY; Men K; Qin Z; Yang Y; Xu T; Wei YQ
Sci China Life Sci; 2017 May; 60(5):458-467. PubMed ID: 28527117
[TBL] [Abstract][Full Text] [Related]
10. Target binding and residence: a new determinant of DNA double-strand break repair pathway choice in CRISPR/Cas9 genome editing.
Feng Y; Liu S; Chen R; Xie A
J Zhejiang Univ Sci B; 2021 Jan; 22(1):73-86. PubMed ID: 33448189
[TBL] [Abstract][Full Text] [Related]
11. [Design of Guide RNA for CRISPR/Cas Plant Genome Editing].
Gerashchenkov GA; Rozhnova NA; Kuluev BR; Kiryanova OY; Gumerova GR; Knyazev AV; Vershinina ZR; Mikhailova EV; Chemeris DA; Matniyazov RT; Baimiev AK; Gubaidullin IM; Baimiev AK; Chemeris AV
Mol Biol (Mosk); 2020; 54(1):29-50. PubMed ID: 32163387
[TBL] [Abstract][Full Text] [Related]
12. Mismatch Intolerance of 5'-Truncated sgRNAs in CRISPR/Cas9 Enables Efficient Microbial Single-Base Genome Editing.
Lee HJ; Kim HJ; Lee SJ
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208669
[TBL] [Abstract][Full Text] [Related]
13. Cell-Penetrating Peptide-Mediated Delivery of Cas9 Protein and Guide RNA for Genome Editing.
Suresh B; Ramakrishna S; Kim H
Methods Mol Biol; 2017; 1507():81-94. PubMed ID: 27832534
[TBL] [Abstract][Full Text] [Related]
14. Highly specific and efficient CRISPR/Cas9-catalyzed homology-directed repair in Drosophila.
Gratz SJ; Ukken FP; Rubinstein CD; Thiede G; Donohue LK; Cummings AM; O'Connor-Giles KM
Genetics; 2014 Apr; 196(4):961-71. PubMed ID: 24478335
[TBL] [Abstract][Full Text] [Related]
15. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
[TBL] [Abstract][Full Text] [Related]
16. Amplification-free long-read sequencing reveals unforeseen CRISPR-Cas9 off-target activity.
Höijer I; Johansson J; Gudmundsson S; Chin CS; Bunikis I; Häggqvist S; Emmanouilidou A; Wilbe M; den Hoed M; Bondeson ML; Feuk L; Gyllensten U; Ameur A
Genome Biol; 2020 Dec; 21(1):290. PubMed ID: 33261648
[TBL] [Abstract][Full Text] [Related]
17. Potential pitfalls of CRISPR/Cas9-mediated genome editing.
Peng R; Lin G; Li J
FEBS J; 2016 Apr; 283(7):1218-31. PubMed ID: 26535798
[TBL] [Abstract][Full Text] [Related]
18. Potential high-frequency off-target mutagenesis induced by CRISPR/Cas9 in Arabidopsis and its prevention.
Zhang Q; Xing HL; Wang ZP; Zhang HY; Yang F; Wang XC; Chen QJ
Plant Mol Biol; 2018 Mar; 96(4-5):445-456. PubMed ID: 29476306
[TBL] [Abstract][Full Text] [Related]
19. Simplified CRISPR-Mediated DNA Editing in Multicellular Eukaryotes.
Kumar R; Tiwari K; Saudagar P
Methods Mol Biol; 2023; 2575():241-260. PubMed ID: 36301478
[TBL] [Abstract][Full Text] [Related]
20. Strategies to Increase On-Target and Reduce Off-Target Effects of the CRISPR/Cas9 System in Plants.
Hajiahmadi Z; Movahedi A; Wei H; Li D; Orooji Y; Ruan H; Zhuge Q
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
